Oncolytics Biotech (Oncolytics Biotech) Ending Cash Position : $26.02 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Oncolytics Biotech Ending Cash Position?

Oncolytics Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 was $26.02 Mil.

Oncolytics Biotech's quarterly Ending Cash Position increased from Jun. 2023 ($13.19 Mil) to Sep. 2023 ($29.55 Mil) but then declined from Sep. 2023 ($29.55 Mil) to Dec. 2023 ($26.02 Mil).

Oncolytics Biotech's annual Ending Cash Position declined from Dec. 2021 ($32.24 Mil) to Dec. 2022 ($8.59 Mil) but then increased from Dec. 2022 ($8.59 Mil) to Dec. 2023 ($26.02 Mil).

Oncolytics Biotech Ending Cash Position Historical Data

The historical data trend for Oncolytics Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Ending Cash Position Chart

Oncolytics Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

10.74

24.37

32.24

8.59

26.02

Oncolytics Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															8.59	11.60	13.19	29.55	26.02

Oncolytics Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Oncolytics Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8.696	+	17.327
	=	26.02

Oncolytics Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	29.802	+	-3.779
	=	26.02

Oncolytics Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Oncolytics Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolytics Biotech (Oncolytics Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (NAS:ONCY) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ONC:Canada

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.